ANI Pharmaceuticals, Inc.
ANIPNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 23, 2026 close
- Market cap
- $1.59B
- P/E (TTM)
- 15.04
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $69.58$97.00
- Volume (live)
- -
- Avg. volume (3M)
- 401.67K
ANI Pharmaceuticals (ANIP) Stock Price & Financial Analysis
ANI Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $72.05 - $73.42 |
|---|---|
| 52-Week High | $97.00 |
| 52-Week Low | $69.58 |
| Open | $73.30 |
| Volume (last close) | 315.34K |
| Average Volume (3M) | 401.67K |
| Revenue (TTM) | 978.38M |
|---|---|
| Net Income (TTM) | 105.83M |
| Free Cash Flow (TTM) | 145.06M |
| EPS (TTM) | $4.93 |
| Profit Margin | 10.82% |
| Operating Margin | 15.35% |
| Return on Equity (ROE) | 17.72% |
| Debt to Equity | 1.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.59B |
|---|---|
| Shares Outstanding | 21.91M |
| P/E Ratio (TTM) | 15.04 |
| Price to Sales (P/S) | 1.63 |
| Price to Book (P/B) | 2.66 |
| EV/EBITDA | 7.32 |
| 50-Day MA | $73.55 |
|---|---|
| 200-Day MA | $77.98 |
| 1-Year Change | −22.29% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
ANI Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, ANI Pharmaceuticals (ANIP) has a market capitalization of $1.59B. The stock trades at 15.0× trailing earnings and 1.6× sales. Over the trailing twelve months it earned $105.83M on revenue of $978.38M (a 10.8% profit margin) and generated $145.06M of free cash flow. Revenue grew 30.9% year over year.
As of its latest reported balance sheet, it holds $360.21M in cash and securities against $610.49M of debt, a net debt position of $250.28M.
ANI Pharmaceuticals does not currently pay a dividend.
The share price is down 22.3% over the past year. At $72.61 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $69.58 to $97.00, below its 200-day moving average of $77.98.
Based on 10 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $106.75, 47.0% above the Oct 23, 2026 close.
Frequently Asked Questions About ANI Pharmaceuticals
What is the current stock price for ANIP?
As of the Oct 23, 2026 close, ANIP stock trades at $72.61. The 52-week range is $69.58–$97.00, with a day range of $72.05–$73.42.
What is the P/E ratio for ANIP?
As of the Oct 23, 2026 close, ANI Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 15.0, meaning investors pay $15.0 for every $1 of annual earnings. ANI Pharmaceuticals operates in the Healthcare sector.
Does ANIP pay dividends?
ANI Pharmaceuticals does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ANIP?
Based on ratings from 10 professional analysts over the last 90 days, the consensus for ANIP is Buy. The average 12-month price target is $106.75, a 47.0% upside from the Oct 23, 2026 close of $72.61.
What is the market cap of ANIP?
As of the Oct 23, 2026 close, ANI Pharmaceuticals's market capitalization is $1.59B, classifying it as a small-cap company. ANI Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.